Nestle India shares surged over 8% to a record high after the company posted strong Q4 FY26 results, with net profit rising 27% YoY to Rs 1,111 crore and revenue up 23%. Robust volume growth, higher advertising spends, and strong performance across key brands boosted investor sentiment.
Ace investor Vijay Kedia boosted his smallcap exposure in Q4 by acquiring 4.53% in Mahamaya Lifesciences and 1.88% in SPML Infra. Kedia, known for spotting multibaggers early, added these picks as both firms show improving momentum, aligning with his long-standing preference for SME and niche growth stories.
The Indian rupee logged its steepest fall in a week on Tuesday, tracking weakness in most regional peers and also weighed down by the partial rollback of measures the central bank had undertaken recently to support the strained South Asian currency.
MFs are ramping up exposure to smallcaps, with 13 picks soaring up to 115% in six months and three turning multibaggers.
Nestle India Q4 Results: Nestle India reported a robust 27% year-on-year rise in consolidated net profit to Rs 1,111 crore for the March quarter, exceeding market expectations. Revenue from operations also saw a significant 23% jump to Rs 6,748 crore.
Indian markets extended gains for a third straight session, supported by easing oil prices and optimism around US-Iran talks. Sensex and Nifty rose sharply, adding over Rs 8 lakh crore in market capitalisation. Broader markets and realty stocks led gains, while declining volatility signalled improving investor sentiment.
Export-oriented shrimp and textile stocks rallied up to 7% on Tuesday after the US began rolling out refunds for tariffs imposed during Donald Trump’s presidency, following a Supreme Court ruling that struck them down. Companies like Gokaldas Exports and Avanti Feeds saw strong gains as investors bet on improved US demand and stability ahead.
Derivatives business faces a structural reset post FY25 regulatory changes, with growth now driven by a smaller but stable customer base, increased market volatility, and an evolving product mix. Despite a dip in equity derivatives participation, future growth is anticipated from overall industry expansion and increasing per-user activity as younger investors engage more.
A report by CoinSwitch shows Indian investors are most active in crypto trading between 10–11 PM, reflecting a preference for post-work hours. Despite 24/7 markets, weekday trading dominates, indicating a shift toward more disciplined, routine-driven investing.
Shares of Anthem BioSciences rose after Citi initiated coverage with a Buy rating and a target price of ₹870, implying over 20% upside. Analysts cited strong growth prospects, a robust portfolio of commercial molecules, sticky client relationships, and scalable manufacturing capabilities supporting long-term revenue visibility.
Warning! Information Posting in this website is only for educational purpose. We are not responsible for losses incurred in Trading based on this information.